Ze-Rong Cai
Overview
Explore the profile of Ze-Rong Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
541
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai Z, Zheng Y, Hu Y, Ma M, Wu Y, Liu J, et al.
Gut
. 2025 Jan;
PMID: 39753334
Background And Objective: Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic methods are lacking. Exosome non-coding RNAs (ncRNAs), a type of liquid biopsy, have emerged...
2.
Hu Y, Cai Z, Huang R, Wang D, Ju H, Chen D
Mol Cancer
. 2024 Dec;
23(1):272.
PMID: 39695693
Background: Most Colorectal Cancer (CRC) patients exhibit limited responsiveness to anti-programmed cell death protein 1 (PD-1) therapy, with the underlying mechanisms remaining elusive. Circular RNAs (circRNAs) play a significant role...
3.
Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints
Cai Z, Wang W, Chen D, Chen H, Hu Y, Luo X, et al.
EMBO Mol Med
. 2024 Nov;
16(12):3089-3112.
PMID: 39543322
Early detection is warranted to improve prognosis of gastric cancer (GC) but remains challenging. Liquid biopsy combined with machine learning will provide new insights into diagnostic strategies of GC. Lipid...
4.
Cai Z, Hu Y, Liao K, Li H, Chen D, Ju H
Cancer Lett
. 2022 Oct;
552:215978.
PMID: 36283584
Aberrant glucose metabolism is one of the most striking characteristics of metabolic reprogramming in cancer. Thus, clarifying the regulatory mechanism of glucose metabolism is crucial to understanding tumor progression and...
5.
Chen Y, Yu Z, Lv M, Cai Z, Zou Y, Lan P, et al.
Mol Med
. 2021 Oct;
27(1):139.
PMID: 34717544
Background: Cancer-associated fibroblasts (CAFs) in the tumour microenvironment are associated with poor prognosis and chemoresistance in multiple solid tumours. However, there is a lack of universal measures of CAFs in...
6.
Chen Y, Yu Z, Lv M, Zheng B, Tan Y, Ke J, et al.
Front Med (Lausanne)
. 2021 Jul;
8:686885.
PMID: 34211990
Hypoxia is associated with a poorer clinical outcome and resistance to chemotherapy in solid tumors; identifying hypoxic-related colorectal cancer (CRC) and revealing its mechanism are important. The aim of this...
7.
Yu Z, Chen Y, Zheng B, Cai Z, Zou Y, Ke J, et al.
Cancer Cell Int
. 2021 Mar;
21(1):176.
PMID: 33736644
No abstract available.
8.
Yu Z, Chen Y, Zheng B, Cai Z, Zou Y, Ke J, et al.
Cancer Cell Int
. 2021 Feb;
21(1):94.
PMID: 33549114
Background: Cancer stem cells (CSCs) are a small subpopulation of cells within tumors with stem cell property. Increased evidence suggest that CSCs could be responsible for chemoresistance and recurrence in...
9.
Zhou W, Cai Z, Liu J, Wang D, Ju H, Xu R
Mol Cancer
. 2020 Dec;
19(1):172.
PMID: 33317550
Circular RNAs (CircRNAs) are single-stranded, covalently closed RNA molecules that are ubiquitous across species ranging from viruses to mammals. Important advances have been made in the biogenesis, regulation, localization, degradation...
10.
Ke J, Liu X, Jiang X, He Z, Xiao J, Zheng B, et al.
Eur J Surg Oncol
. 2020 Sep;
46(10 Pt B):e62-e70.
PMID: 32863096
Aim: Immune-related genes are associated with the prognosis of colorectal cancer (CRC) patients. The aim of this study was to evaluate the impact of an immune-related gene signature (IRGS) in...